Research Intern, Diagnostic Innovation

OPPORTUNITY
Mammoth is seeking a Research Intern to join its Diagnostics team to advance our efforts towards integrating novel readout methods with our DETECTR® platform.

CRISPR diagnostic chemistry is highly flexible and is compatible with many different readouts, such as fluorescence and lateral flow strips. The Assay Innovation team is particularly interested in building assays that generate a visible color change which will allow the results to be easily interpreted by the end user. The intern in this role will help explore coupling CRISPR to these approaches. This is an excellent learning opportunity for students who might be interested in transitioning to industry and experiencing life at a cutting edge biotech start-up.
KEY RESPONSIBILITIES

• Work directly with Scientists and Research Associates to design and perform activity assays using colorimetric, electrochemical, and fluorogenic enzymes
• Execution of established molecular biology and biochemistry workflows (functional assays and reagent preparation)
• Document experimental results in laboratory notebooks
• Present experimental results at internal meetings
• Other duties as assigned 

REQUIRED QUALIFICATIONS

• Pursuing a bachelor's degree in molecular biology, biochemistry, bioengineering, or a related field
• 0-1 year of experience working in a laboratory environment

PREFERRED QUALIFICATIONS

• Hands-on experience in common lab techniques such as filtering, centrifugation, reagent dilutions, buffer preparation
• Familiarity with laboratory equipment such as analytical balance, plate reader or spectrophotometer
• Experience with electronic documentation 
• Desire to learn and adapt to a fast-paced, highly collaborative team environment

Mammoth Biosciences is harnessing the diversity of life to power the next generation of CRISPR products. Through the discovery and engineering of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth aims to develop permanent genetic cures through best-in-class in vivo and ex vivo therapies and to democratize disease detection with on-demand diagnostics. Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in the San Francisco Bay Area, Mammoth Biosciences is co-founded by CRISPR pioneer and Nobel Laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Decheng, Mayfield, NFX, and 8VC, along with leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.

TEAM
The Diagnostics team is advancing our CRISPR-based DETECTR® platform to address unmet needs across the continuum of testing. From laboratories to the home, our mission is to democratize diagnostics with CRISPR. 

It is our policy and intent to provide equal opportunity to all persons without regard to race, color, religion, political affiliation, sex/gender (including gender expression/identity, pregnancy, childbirth and related medical conditions), marital status, registered domestic partner status, sexual orientation, age, ancestry, national origin, veteran status, disability, medical condition, genetic characteristics, and/or any other basis protected by law.  This policy covers all facets of employment including, but not limited to: recruitment, selection, placement, promotions, transfers, demotions, terminations, training, and compensation.